Biocept Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
134.20
133.40
609.90
3,223.10
5,068.70
3,250.30
Cost of Goods Sold (COGS) incl. D&A
2,329.90
2,170.50
4,596.20
6,920.10
9,345.10
10,051.70
Gross Income
2,195.70
2,037.10
3,986.20
3,697.00
4,276.50
6,801.40
SG&A Expense
5,748.80
11,836.80
12,424.60
14,328.00
16,898.20
17,457.30
EBIT
7,944.40
13,873.90
16,410.80
18,025.00
21,174.70
24,258.70
Unusual Expense
782.10
200.90
0.90
-
-
-
Non Operating Income/Expense
-
-
102.40
153.70
51.20
-
Interest Expense
2,070.10
1,789.70
640.50
525.90
482.60
311
Pretax Income
9,232.40
15,864.50
16,947.90
18,397.30
21,606.10
24,569.70
Income Tax
0.80
1.50
1.60
2.10
7.60
1.90
Consolidated Net Income
9,233.20
15,866.00
16,949.50
18,399.30
21,613.70
24,571.60
Net Income
9,233.20
15,866.00
16,949.50
18,399.30
21,613.70
24,571.60
Net Income After Extraordinaries
9,233.20
15,866.00
16,949.50
18,399.30
21,613.70
24,571.60
Net Income Available to Common
9,233.20
15,866.00
16,949.50
18,399.30
21,613.70
25,208
EPS (Basic)
60.88
357.18
91.80
57.60
23.70
9.01
Basic Shares Outstanding
151.70
44.40
183.80
319.30
908.20
2,798.20
EPS (Diluted)
60.88
357.18
92.23
57.63
23.80
9.01
Diluted Shares Outstanding
151.70
44.40
183.80
319.30
908.20
2,798.20
EBITDA
7,677.90
13,622.70
16,149.40
17,703.00
20,599.00
23,457.80
About Biocept
View Profile
